Table 1

Included interventions

Active ingredientFormBrand name
DarifenacinOral Extended-release tabletEnablex
Flavoxate hydrochlorideOral tabletUrispas
Hyoscyamine sulfateOral tabletLevsin
Oxybutynin chlorideOral tablet and syrupDitropan
Oxybutynin chlorideExtended release oral tabletDitropan XL
OxybutyninTransdermal systemOxytrol
Scopolamine (hyoscine) butylbromideOral tabletBuscopan
Solifenacin succinateOral tabletVesicare
Tolterodine tartrateOral tabletDetrol
Tolterodine tartrateExtended release oral capsuleDetrol LA
Trospium chlorideOral tabletSanctura (USA), Trosec (Canada)
Trospium chlorideExtended release oral capsuleSanctura XRa

Not available in Canada.

From: Methods

Cover of Drug Class Review: Agents for Overactive Bladder
Drug Class Review: Agents for Overactive Bladder: Final Report Update 4 [Internet].
McDonagh MS, Selover D, Santa J, et al.
Portland (OR): Oregon Health & Science University; 2009 Mar.
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.